Body Dysmorphic Disorder (BDD) is a psychological disorder characterized by the persistent preoccupation with one or more perceived defects in physical appearance that are not observable or appear slight to others (American Psychiatric Association [APA], 2013), which is currently included into the “Obsessive-Compulsive and Related Disorders” category of the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5; APA, 2013). Although any body part can be the focus of concerns, the most common areas of concern in people with BDD are the skin (presence of acne or scars), the hair (hair loss, thinning, or excessive facial or body hair), and the nose (shape or size; Phillips 2006; Phillips & Diaz 1997; Phillips, McElroy, Keck, Pope, & Hudson, 1993; Veale et al., 1996), and individuals with BDD may be concerned with multiple body parts at the same time (Phillips et al., 1993; 2005). In response to the appearance concerns, individuals with BDD engage in repetitive and time-consuming behaviors and mental actions focused on examining, being reassured about, and hiding perceived defects (Phillips & Diaz, 1997; Phillips, Menard, Fay, & Weisberg, 2005). The most common are: camouflaging (e.g., with hair, makeup, body position, or sunglasses), checking the perceived defect in mirrors or other reflecting surfaces (e.g., windows), excessively grooming (e.g., applying makeup or styling hair), seeking reassurance from family and friends about the defect, repeatedly touching the disliked areas, and comparing one’s appearance with that of other people (Phillips, 2009; Phillips & Diaz, 1997; Phillips et al., 2005; Veale & Riley, 2001). Behaviors are unlimited (Phillips, 1998) and can include seeking plastic surgery or cosmetic medical treatments in order to reduce the perceived defects (Crerand, Phillips, Menard, & Fay, 2005; Phillips, Grant, Siniscalchi, & Albertini, 2001); these procedures, however, are not beneficial (Crerand et al., 2005; Phillips et al., 2001) and do not typically result in a decrease of BDD symptoms severity (Crerand et al., 2005; Phillips et al., 1993; Phillips et al., 2001). Rather, some patients with BDD experience symptoms exacerbation and development of new appearance concerns (Crerand et al., 2005; Phillips et al., 2001; Veale, 2000; Veale et al., 1996). In addition to core concerns about appearance, BDD is characterized by low self-esteem, high perfectionism, and high comorbidity rate (Phillips, 2006; Phillips et al., 1993; Phillips et al., 2005). The most common associated disorders are: Major Depressive Disorder (MDD), Social Anxiety Disorder (SAD), Obsessive Compulsive Disorder (OCD), and Anorexia Nervosa (AN; Dingemans, van Rood, de Groot, & van Furth, 2012; Grant, Kim, & Eckert, 2002; Gunstad & Phillips, 2003). Despite increased awareness of BDD in recent years, it continues to be an under-studied disorder (Buhlmann & Winter, 2011; Buhlmann et al., 2010), particularly in the Italian context. Indeed, little is known about BDD prevalence and phenomenology in Italy, and no data are available on BDD prevalence rates using DSM-5 criteria (APA, 2013) in the Italian general population. Therefore, the current dissertation aimed at assessing BDD prevalence, phenomenology, associated clinical features, and at risk populations through three studies. The first study aimed at exploring the prevalence and the phenomenology of BDD in an Italian community sample and its associated clinical features such as self-esteem, perfectionistic traits, social anxiety, depressive, and obsessive-compulsive symptoms. Six hundred and fifteen community individuals completed a battery of self-report questionnaires assessing the above-mentioned clinical features. Results showed that 10 (1.63%) individuals met DSM-5 criteria (APA, 2013) for BDD. Hair (n = 4; 4%), nose (n = 4; 4%), and teeth (n = 4; 4%) were the most common areas of concern. With respect to the associated clinical features, individuals who satisfied BDD diagnostic criteria reported lower levels of self-esteem, more severe social anxiety symptomatology, general distress, depression, and obsessive-compulsive features than people without BDD. These findings outlined that, within the Italian context, BDD is a relatively common psychological disorder associated with significant morbidity. The second study of the current dissertation focused on the shared clinical features between BDD and AN. Indeed, both the psychopathologies are severe body image disorders (Rosen, Reiter, & Orosan, 1995) characterized by body image disturbance and dissatisfaction, intrusive thoughts about appearance, and by an overemphasis on appearance in the evaluation of self-worth (Rosen & Ramirez, 1998). Furthermore, both BDD and AN are characterized by low self-esteem (Phillips, Pinto, & Jain, 2004; Rosen & Ramirez, 1998) and high levels of perfectionism (Bardone-Cone et al., 2007; Buhlmann, Etcoff, & Wilhelm, 2008; Bulik et al., 2003; Veale, 2004). Many studies underlined the high comorbidity between BDD and AN (Dingemans et al., 2012; Fenwick & Sullivan, 2011; Grant et al., 2002; Kollei, Schieber, Zwaan, Svitak, & Martin, 2013; Ruffolo, Phillips, Menard, Fay, & Weisberg, 2006), and patients with AN frequently report nonweight-related body image concerns (Dingemans et al., 2012; Grant et al., 2002; Kollei et al., 2013). Furthermore, patients with AN and comorbid BDD report greater body image dissatisfaction and clinical symptomatology than those without comorbid BDD (Dingemans et al., 2012; Grant et al., 2002). Therefore, the first aim of this study was to assess the prevalence of BDD and the presence of nonweight- related body image concerns in patients with AN. Secondly, the study aimed at comparing patients with AN and nonweight-related body image concerns, patients with weight-related body image concerns only and a healthy control group with respect to body image and psychological and psychopathological features. For these purposes, 61 patients with AN were divided in two groups: 39 with nonweight-related body image concerns and 22 with weight-related body image concerns only. Furthermore, a group of 61 healthy controls was recruited. Main results of this study showed that 16 (26.23%) patients with AN had probable comorbid BDD. The most common nonweight-related body image concerns were: hair (41.02%), nose (30.77%), skin (30.77%), teeth (25.64%), and height (20.51%). Moreover, patients with AN and nonweight-related body image concerns reported greater levels of psychopathology not related to eating disorder than patients with weight-related body image concerns only, in accordance with previous studies (Dingemans et al., 2012; Grant et al., 2002). In conclusion, patients with AN and nonweight-related body image concerns showed a more severe body image disturbance unrelated to a more severe eating disorder. Lastly, the third study of the current dissertation aimed at assessing the prevalence of Muscle Dysmorphia (MD), its associated psychological features and possible predictors among 3 groups (N = 125) of Italian recreational athletes. MD is a subtype of BDD characterized by the preoccupation with the idea that one’s body is not sufficiently lean and muscular (APA, 2013; Pope, Gruber, Choi, Olivardia, & Phillips, 1997); however, individuals with MD have a normal-looking body or are even very muscular, much more than the average of people (Pope et al., 1997). The first aim of this study was to explore the prevalence and the phenomenology of MD in 3 groups of Italian participants who trained regularly for recreational purposes: 42 bodybuilders, 61 strength trainers, and 22 fitness wellness trainers. Secondly, we aimed at investigating MD related behaviours and psychological features such as self-esteem, perfectionistic traits, social anxiety and orthorexia nervosa symptoms, and general distress among groups. Lastly, we aimed at assessing the presence of associations between MD and related psychological features among the 3 groups and, with exploratory purposes, possible MD predictors among groups. Results revealed a MD prevalence of 6.4%: 4 participants (9.52%) in the bodybuilding group, 2 participants (3.28%) in the strength group, and 2 participants (9.09%) in the fitness/wellness group satisfied Pope et al. (1997) diagnostic criteria for MD. With respect to MD associated cognitive and behavioural symptoms, the bodybuilding group reported more frequently to think about taking anabolic- androgenic steroids (AAS), to assume more than 2 daily grams of proteins, and to experience more beliefs about being smaller and weaker than desired or wishes to be more muscular than the other groups, whereas this group reported more MD general symptomatology only with respect to the fitness/wellness group. Moreover, the strength group reported to set higher standards for themselves than the other two groups. Finally, different correlational patterns among group emerged, as well as different MD predictors. Specifically, social anxiety symptoms resulted significant predictors of MD symptomatology for both the bodybuilding and the strength group, whereas no predictors emerged for the fitness/wellness group. In conclusion, results of this study underlined that the pursuit of a lean and muscular physique in bodybuilding is not always associated with MD and related psychological features. To conclude, this dissertation provides clinical hints as far as concern both preventive strategies and psychological treatment implications for BDD across at risk populations.